• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Remdesivir

Remdesivir

  • Covid Update

    'Collect evidence against suppliers not cutting prices'

    The Central Board of Indirect Taxes and Customs (CBIC) had on June 14 notified reduced GST rate on 18 Covid-19-related supplies

  • Covid Update

    Covid-19 impact | Are Indians spending too much on immunity boosters?

    Indians bought nearly Rs 15,000 crore of vitamin supplements and other immunity boosters between June 2020 to May 2021, according to AIOCD data

  • Covid Update

    Biophore applies to DCGI for emergency-use approval for Covid treatment drug

    Biophore plans to commence commercial production of Aviptadil immediately after the approval.

  • Covid Update

    Centre issues advisory for rational use of Remdesivir in Covid-19 treatment

    Remdesivir should be provided by the hospitals, and patient's relatives should not be asked to procure it from the retail market, the advisory said

  • Covid Update

    States allocated 98.87 lakh vials of Remdesivir so far: Sadananda Gowda

    With a massive surge in coronavirus infections across the country, demand for Remdesivir has gone up manifold

  • Covid Update

    Union health minister asks Ramdev to withdraw statement on allopathic medicines

    "The statement disrespects the corona warriors and hurts the sentiments of the country," Union health minister Harsh Vardhan said in a letter to Ramde

  • Equities

    LIC has raised stake in this pharma major amid Covid 2.0; should you invest?

    The company recently informed bourses that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for expandin

  • Opinion

    Money9 Edit | Covid kit price control key to mitigation

    Ramping up medical infrastructure is going to take its own time. But to bring immediate relief for pricing of Covid essentials, the union government m

  • Covid Update

    Government boosts production of Remdesivir from 38 lakh to 119 lakh vials a month

    With the accelerated approval of 38 additional production sites, the number of approved manufacturing sites of Remdesivir in India has gone up, from e

  • Covid Update

    Covid-19 patients on homecare should not take Remdesivir: AIIMS doctors

    Suggesting measures Covid-19 patients need to take to manage the infection, the doctors said sanitisation, cleanliness, use of medical grade masks and

  • 1
  • 2
  • 3
  • 4
  • →

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close